{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:20:04Z","timestamp":1783948804179,"version":"3.55.0"},"reference-count":0,"publisher":"Harborside Press, LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Natl Compr Canc Netw"],"published-print":{"date-parts":[[2006,3]]},"abstract":"<jats:p>Marginal zone lymphomas (MZLs) comprise 3 distinct entities: extranodal MZL of mucosa-associated lymphoid tissue (MALT), splenic MZL, and nodal MZL. Gastric MALT lymphoma is the most common extranodal MZL and often develops as a result of chronic <jats:italic>Helicobacter pylori<\/jats:italic> gastritis. Such cases frequently respond to antibiotics directed against <jats:italic>H. pylori<\/jats:italic>. Antigen-driven lymphomatous disease can also be seen in the association of <jats:italic>Borrelia burgdorferi<\/jats:italic> with MALT lymphoma of the skin, <jats:italic>Chlamydia psittaci<\/jats:italic> with MALT lymphoma of the ocular adnexa, <jats:italic>Campylobacter jejuni<\/jats:italic> with immunoproliferative disease of the small intestine, and hepatitis C with splenic MZL. This article discusses the pathogenesis and clinical features of MZL and the treatment options available to patients.<\/jats:p>","DOI":"10.6004\/jnccn.2006.0026","type":"journal-article","created":{"date-parts":[[2017,4,14]],"date-time":"2017-04-14T15:53:00Z","timestamp":1492185180000},"page":"311-318","source":"Crossref","is-referenced-by-count":36,"title":["Marginal Zone Lymphoma"],"prefix":"10.6004","volume":"4","author":[{"given":"Omid S.","family":"Shaye","sequence":"first","affiliation":[{"name":"From the Division of Hematology, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra M.","family":"Levine","sequence":"additional","affiliation":[{"name":"From the Division of Hematology, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4047","container-title":["Journal of the National Comprehensive Cancer Network"],"original-title":[],"link":[{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/4\/3\/article-p311.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T19:31:04Z","timestamp":1551382264000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/4\/3\/article-p311.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":0,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.6004\/jnccn.2006.0026","relation":{},"ISSN":["1540-1405","1540-1413"],"issn-type":[{"value":"1540-1405","type":"print"},{"value":"1540-1413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}